-
26 Oct 2026
Ris-Rez reduced risk of disease progression or death by 67% versus chemotherapy in patients with relapsed osteosarcoma in China
by GSK News Feed
- Views 5
- More stats
-
12 Dec 2025
GSK’s RSV vaccine, Arexvy, receives positive CHMP opinion for all adults 18 years and older
by GSK News Feed
- Views 4
- More stats
-
12 Dec 2025
Depemokimab receives positive CHMP opinion for severe asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
by GSK News Feed
- Views 4
- More stats
-
12 Dec 2025
Nucala (mepolizumab) receives positive CHMP opinion for treatment of chronic obstructive pulmonary disease (COPD)
by GSK News Feed
- Views 4
- More stats
-
15 Dec 2025
Exdensur (depemokimab) approved in the UK for treatment of asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps
by GSK News Feed
- Views 4
- More stats
-
19 Dec 2025
GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans
by GSK News Feed
- Views 4
- More stats
-
10 Feb 2026
GSK’s RSV vaccine, Arexvy, accepted for regulatory review in China for adults aged 60 years and older
by GSK News Feed
- Views 4
- More stats
-
18 Feb 2026
ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM
by GSK News Feed
- Views 4
- More stats
-
25 Feb 2026
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing
by GSK News Feed
- Views 4
- More stats
-
25 Feb 2026
ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen
by GSK News Feed
- Views 4
- More stats
Latest News in Life Sciences
Read the latest news, announcements and press releases from life sciences and related disciplines, including news from biotechnology and pharmaceutical research and development. When you join Life Science Network, you can follow your favorite sources to get notified when content matching your interests is published.
You can post a news article here
Join Life Science Network
Join LSN to acces all jobs and fully benefit from the platform and its features.
News module
Are you interested in posting articles on Life Science Network?
Please continue reading here.
For more information about Life Science Network,
contact us at [email protected].
Advertisement